Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-028362
Filing Date
2026-04-29
Accepted
2026-04-29 16:06:08
Documents
95
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-20260331.htm   iXBRL 10-Q 1338853
2 EX-31.1 q12026-exhibitx311.htm EX-31.1 9560
3 EX-31.2 q12026-exhibitx312.htm EX-31.2 9886
4 EX-32.1 q12026-exhibitx321.htm EX-32.1 3934
5 EX-32.2 q12026-exhibitx322.htm EX-32.2 3831
  Complete submission text file 0001628280-26-028362.txt   7468112

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20260331.xsd EX-101.SCH 61688
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbio-20260331_cal.xml EX-101.CAL 54710
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbio-20260331_def.xml EX-101.DEF 391400
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20260331_lab.xml EX-101.LAB 689065
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20260331_pre.xml EX-101.PRE 580753
99 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20260331_htm.xml XML 746531
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 26915881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)